The pharmaceutical industry is on the verge of a major transformation thanks to the integration of artificial intelligence into the drug design process. This innovation has the potential to make drug development faster, more cost-effective, and efficient. Traditional drug design and development have been time-consuming and expensive, but AI can expedite the process, reducing both time and cost. AI can quickly identify promising compounds, accelerate the validation of drug targets, and optimize drug structure designs, enabling the development of drugs at a fraction of the time and cost.